|Articles|May 1, 2018
- BioPharm International-05-01-2018
- Volume 31
- Issue 5
BioPharm International, May 2018 Issue (PDF)
Click the title above to open the BioPharm International May 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Harmonization of Batch Recordsover 7 years ago
Gottlieb Tackles Tough Issues in First Year at FDAover 7 years ago
Understanding Validation and Technical Transfer, Part 2over 7 years ago
Leveraging Data for Better Biopharmaceutical Process Controlover 7 years ago
Key Ingredients to Healthcare’s Futureover 7 years ago
NIST Spectroscopic Measurement Standardsover 7 years ago
Managing Uncertainty in Continuous Biomanufacturingover 7 years ago
Putting Viral Clearance Capabilities to the Testover 7 years ago
CDMOs Driving Emerging Bio/Pharma SuccessNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
4
$1.8M RedHill Deal Highlights Growing Worldwide Focus on H. pylori Treatment Access
5
